Picture of So-Young International logo

SY — So-Young International News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeSmall CapNeutral

China's So-Young Q2 revenue rises, net loss narrows

China's So-Young Q2 revenue rises, net loss narrows


Overview

  • China aesthetic treatment platform's Q2 revenue rose 33% yr/yr, driven by branded center expansion

  • Net loss for Q2 narrowed yr/yr, reflecting improved operational efficiency

  • Company expects Q3 aesthetic treatment services revenue to nearly double yr/yr


Outlook

  • So-Young expects Q3 2026 aesthetic treatment services revenue of RMB352 mln to RMB362 mln

  • Company plans to accelerate AI-powered transformation and strengthen supply chain

  • Company sees a clear path toward profitability as economies of scale continue to unfold


Result Drivers

  • BRANDED CENTER EXPANSION - Co attributed revenue and treatment volume growth to expansion of branded aesthetic centers

  • USER GROWTH - Verified treatment visits and active users rose sharply, indicating strong demand and effective user acquisition

  • AI AND DELIVERY SYSTEMS - Management cited enhanced medical capabilities, standardized delivery system, and deeper AI integration as supporting efficient scaling


Company press release: ID:nPn3zPrPQa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

RMB 505.23 mln

Q2 Net Loss

RMB 22.70 mln

Q2 Gross Profit

RMB 222.85 mln

Q2 Income from Operations

-RMB 43.63 mln

Q2 Operating Expenses

RMB 266.48 mln

Q2 Pretax Loss

RMB 27.15 mln


Analyst Coverage

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the miscellaneous specialty retailers peer group is "buy."

  • Wall Street's median 12-month price target for So-Young International Inc is $7.30, about 204.2% above its August 28 closing price of $2.40


Reuters Recommended Reads

  • Aug 31 - China's Ingdan interim revenue rises on AI chip demand

  • Aug 31 - China's HeartCare Medical H1 revenue surges on stroke segment growth

  • Aug 31 - Chinese factory slump eases, but weak services signal uneven recovery


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on So-Young International

See all news